AR091979A1 - Cepas atenuadas de parasitos para la prevencion o el tratamiento de patologias asociadas a un apicomplejo - Google Patents

Cepas atenuadas de parasitos para la prevencion o el tratamiento de patologias asociadas a un apicomplejo

Info

Publication number
AR091979A1
AR091979A1 ARP130102759A ARP130102759A AR091979A1 AR 091979 A1 AR091979 A1 AR 091979A1 AR P130102759 A ARP130102759 A AR P130102759A AR P130102759 A ARP130102759 A AR P130102759A AR 091979 A1 AR091979 A1 AR 091979A1
Authority
AR
Argentina
Prior art keywords
mic
prevention
treatment
attentioned
beekeeping
Prior art date
Application number
ARP130102759A
Other languages
English (en)
Inventor
Gnahoui-David Audrey
Mevelec Marie
Nolle-Seche Edouard
Laurent Fabrice
Original Assignee
Vitamfero
Agronomique Inst Nat Rech
Univ Francois Rabelais De Tours
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vitamfero, Agronomique Inst Nat Rech, Univ Francois Rabelais De Tours filed Critical Vitamfero
Publication of AR091979A1 publication Critical patent/AR091979A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/012—Coccidia antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente tiene por objeto las cepas de Sarcocystidae elegidas entre Toxoplasma spp o Neospora spp aisladas de su medio natural y que poseen un efecto inmunoestimulante para su uso en la prevención o el tratamiento, en un mamífero, de una patología asociada a un parásito del Phylum Apicomplexo de la familia de los Cryptosporidiidae. Las cepas elegidas entre Toxoplasma spp o Neospora spp poseen al menos una adhesina MIC-1 y/o adhesina MIC-3 inactivada por una modificación genética en al menos uno de los genes MIC-1 y/o MIC-3.
ARP130102759A 2012-08-02 2013-08-02 Cepas atenuadas de parasitos para la prevencion o el tratamiento de patologias asociadas a un apicomplejo AR091979A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1257547A FR2994096B1 (fr) 2012-08-02 2012-08-02 Utilisation de souches attenuees de parasites pour la prevention ou le traitement de pathologies associees a un apicomplexe

Publications (1)

Publication Number Publication Date
AR091979A1 true AR091979A1 (es) 2015-03-11

Family

ID=47501366

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130102759A AR091979A1 (es) 2012-08-02 2013-08-02 Cepas atenuadas de parasitos para la prevencion o el tratamiento de patologias asociadas a un apicomplejo

Country Status (10)

Country Link
US (2) US20150165008A1 (es)
EP (1) EP2879698B1 (es)
CN (1) CN104812403A (es)
AR (1) AR091979A1 (es)
AU (1) AU2013298399B2 (es)
BR (1) BR112015002368A8 (es)
CA (1) CA2880843A1 (es)
FR (1) FR2994096B1 (es)
NZ (1) NZ705406A (es)
WO (1) WO2014020290A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2016014868A (es) 2014-05-14 2017-07-19 Merial Inc Metodos para secar por congelacion y rehidratar productos biologicos.
WO2018224656A1 (en) * 2017-06-09 2018-12-13 Université François-Rabelais De Tours Neospora for use in treating cancer and infectious diseases
FR3068364A1 (fr) * 2017-07-03 2019-01-04 Vitamfero Utilisation de souches de sarcocystidae comme vecteurs multirecombinants d'antigenes pour la prevention de maladies infectieuses
CN110183527B (zh) * 2019-05-21 2021-03-12 中国农业大学 一种新孢子虫NcMIC26抗原及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2864966B1 (fr) * 2004-01-13 2006-05-05 Agronomique Inst Nat Rech Souches vaccinales d'apicomplexes de la famille des sarcocystidae.
WO2011011725A2 (en) * 2009-07-24 2011-01-27 Schultz-Cherry Stacey L Use of toxoplasma and derived compositions to prevent or treat microbial infections

Also Published As

Publication number Publication date
CN104812403A (zh) 2015-07-29
AU2013298399B2 (en) 2018-03-15
NZ705406A (en) 2017-11-24
CA2880843A1 (fr) 2014-02-06
US20150165008A1 (en) 2015-06-18
EP2879698A2 (fr) 2015-06-10
AU2013298399A1 (en) 2015-03-12
WO2014020290A3 (fr) 2014-07-17
US20160166662A1 (en) 2016-06-16
BR112015002368A2 (pt) 2017-11-07
US9585949B2 (en) 2017-03-07
EP2879698B1 (fr) 2018-01-17
FR2994096B1 (fr) 2016-03-04
FR2994096A1 (fr) 2014-02-07
BR112015002368A8 (pt) 2018-01-16
WO2014020290A2 (fr) 2014-02-06

Similar Documents

Publication Publication Date Title
CL2017000310A1 (es) Anticuerpos anti tigit
CR11382A (es) Sistema de gestion del conocimiento
CR20160418A (es) Nuevos compuestos biciclicos de 7 eslabones
UY34683A (es) Esteviol glucosiltransferasas y genes que las codifican
EA201291157A1 (ru) Мультивалентные вакцины с синтетическими наноносителями
UY34134A (es) Contenedor aislado
ECSP15011603A (es) Subunidades de vacunas de inmersión para peces
UY34484A (es) Benzotienilo-pirrolotriazinas disustituidas y sus usos
DOP2016000056A (es) Dispositivo para el diagnóstico de infestación
CL2017001292A1 (es) 4-oxo-3,4-dihidro-1,2,3-benzotraizinas como moduladores de gpr139
GB2496214B (en) Amplifying optical device pumped or seeded with nonlinearly generated light
MX2015003834A (es) Uso de material fotocatalitico para autolimpieza de papel moneda.
UY34442A (es) 2-tiopirimidinonas.
AR091979A1 (es) Cepas atenuadas de parasitos para la prevencion o el tratamiento de patologias asociadas a un apicomplejo
JP2013248600A5 (es)
JP2011229212A5 (es)
BR112015009301A2 (pt) biocontrole de nematoides
UY34783A (es) Segadora
HN2010001614A (es) Confitura
UY34702A (es) Composiciones y métodos agrícolas u hortícolas
UY34408A (es) Nuevos moduladores de trpv3
JP2014113267A5 (es)
RU2011132431A (ru) Хлорсодержащие ароматические полиэфиры
RU2011140186A (ru) Галогенсодержащие ароматические полиэфиры
CL2016003148A1 (es) Nueva cepa de tenacibaculum sp

Legal Events

Date Code Title Description
FB Suspension of granting procedure